Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
doi: 10.1016/j.molmet.2014.04.009 112 Russell-JonesDVaagASchmitzOSethiBKLalicNAnticSet al
Mark Orland, who is affiliated with the Taussig Cancer Institute and will present the findings at the ASCO meeting
Food and Drug Administration today initiated the approval of leucovorin calcium tablets for patients with cerebral folate deficiency (CFD), a neurological condition that affects folate (a vitamin essential for brain health) transport into the brain
Thomsen et al., 2019)
Yellow Card scheme report a side effect or adverse incident
US$ 23.56
US$ 23.54
US$ 24.21
